DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Ubidecarenone is an investigational drug.
There have been 8 clinical trials for Ubidecarenone. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2008.
The most common disease conditions in clinical trials are Muscular Diseases, Parkinson Disease, and Gliosarcoma. The leading clinical trial sponsors are Berg, LLC, University of Rochester, and Seema Nagpal.
Recent Clinical Trials for Ubidecarenone
|A Safety Study of Orally Administered BPM31510 in Healthy Subjects||Berg, LLC||Phase 1|
|BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab||National Cancer Institute (NCI)||Phase 1|
|BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab||Seema Nagpal||Phase 1|